Key Insights

Highlights

Treatment Research

2 treatments under study, led by Antihypertensive Algorithm

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05732727Phase 3Recruiting

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

Showing all 1 trials

Research Network

Common Treatments

  • Antihypertensive Algorithm1
  • Standard Of Care1

Active Sponsors

  • University Hospital, Tours1
  • Centre Hospitalier Regional Universitaire De Tours1

Top Investigators

Related Conditions

  • Uncontrolled Hypertension1
  • Chronic Kidney Diseaseckd1

Activity Timeline